. .
nffcctcd by sex; alter t l~c age of 10 ycars wu obxrvcd at, Incrcasc ~n trmk fat amount which was sign~ficantly differc~it lrom the previous ages (pc0.01) Legs la1 content was the best index of total fat mass(r=O 73, pc0.001). Total fat content estimated by DEXA was significantly corrclatcd with ponderal excess est~malcd accordltig to Tantier (r=0.6, pc0.02) and to p<0.001) , as svell as with triceps skinfold (r=0.73, pc0.001). Fat free mass estimated by D20 and by BIA, uslng Bauistini's formula spec~fic for obcsc cliildrcn, svas highly related to lean mass detected by DEXA (r.0.89 p<O 0032 and r=0.91, pcO 001, resp.ctivcly), rvhllc fat mass was not (r=D.29). Our data conilrm feastb~!!ly of DEXA for body composlllon and fat distribution studics, even in cliildrc~i. Arnolig standard a~~tlrropomelric ~ndcxes 01 adiposity, triceps sklnfold seems to assure the best predictlon of total fat amount and BIA appears to bc an accurate method lor total body water cstlrnatlon. Furtlrcr investigations on (at Iiydral~on are needed for a !nore precise measuicmcnt of fat mass using indirect tccniqun. Osteoporosis in the youth most olkn accompanies severe ~llness, such as inborn errors of metabolism, or therapy affccung bone metabolism (c.g. steroid). Calcium supplementation, sodium fluoride, vlwnin D3 and derivatives, catciionin, while effcctivc in relcnung the progression of the disease, are not satisfactory as to recover from conspicuous toss of bone mass. By conuast, increasing cnpcrlcnce is king cottccted in the use of bisphosphonates, a class of molccutes able to ~nh~bit ostcoclastic act~vity of bone resorption. Wc have uealed with 3amino lhydroxy propylidene I,tbiephosphonatc (APD) 5 paticnu agcd 6.5 to 20 ycars, wtth severe osteoporosis: two had primitive bone disease (Gauchcr's d~xasc, familial hypphosphalasia), one was alfcclcd by cyslic librous. two rcceivcd sterojd (lor rhcumaloid anhrit~s and dtcr bonc marrow transplantallon lor acute lcukem~a). Two 01 them had experienced sponmaneous lracmres, the othcrs had mostly limb andior back pain. The calcium conlcnl of bonc had k c n assccscd by mans of computed dcnsltomcvy of lumbar vcncbrac: the figure was rcduccd IO 4-125 mum1 of bone (normal range for age approx. 150-2W). The APD was administered inuavcnously. 5-7.5 mglday for 5 days, then 10 mg once every three wceks. Moderate hypocalccm~a observed aftcr the firat infusions was prcvcntcd by oral calcium supplementauon. 500-1500 mdday lor a fcw days following each infusion. Alter a follow-up ranging 8-12 months, the vcnebral CT scan showed an increase of calcium content by 26 -1325 90. the flgurc atuin~ng nonnal~ty ~n two cucs: the hcst ruull was obtained In ltie bay with the lowest prwcauncnt value. Symp~oms and regional radiographs alsn showed comparable improvement. Side e f f e c~~ were self-limited fever lollowlng infusions in one pauent, and uansicnt call patn in another. We conclude hat APD can be cflcciivcly and .safely used in chlldrcn and adolcsccnu lo cure scvcrc osteoporosis. both prlmirive and iathrogentc. Gonadal steroids are known to play an important role in the control of GH-IGF-I axis and in bone mineral increase that occur during puberty. T o better know the importance of estrogens on bone mineral metabolism during growth and puberty we studied ten girls (age range 6-7.2 yrs.) with true precocious puberty, before and after I year of LHRH analogs treatment. In tliese patients, before starling ueatnient with Leuprolide acetate (Enantone depot-Takeda). 0.2 m d k g administered i.m. every 28 dsys, we performed: a clonidin stimulation test for GH; a 1,25dihydroxyvitaminD3 toad (RocalUol-Rcche) giving a dose of 2 pgi&~y far four consecutive days with the dosage before and after of serum Ca, P, IGF-I and Osteocalcin; a densitometric evaluation (dual photon absorptiometry) of BMC and B D (UMCIBW) in the distal and ultradistal region of the nondominant radius. After 1 year of therapy we repeated the same evaluations. During therapy serum esuadiol levels decreased from pubertal (35.7 + 3.5 pglml) (M+ DS) to prepubertal levels (QO pgiml in each patient) as expected. GH peak after clonidin stimulation lest after treillmcnt was significantly lower tlliln M o r e (18.7 * 2.2 vs 6.8 2 3.5 n@ml; p=0.005). IGF-I levels decreasetl not sigtiificantly at 12 months (from 278 + 38 to 223 F 53 ngiml) and were not influenced by I ,ZS(OH)2D, load, while Osleocalciti levels were in the pubertal range before tllerapy (35.8 + 6,2 nglml), decreased not significantly after therapy, and showed a slight increase after 1,25(OH)zD3 toad both before and after LHRHa Iheravy. Bone m i n e r a l d e n s i t y , gr/cm2, ( BMD ) o f t h e lumbar s p i n e , L2-L4, was measured by d u a l e n e r g y X-ray a b s o r p t i o m e t r y ( Lunar DPX ) i n 9 a n o r e x i a n e r v o s a f e m a l e p a t i e n t s aged 1 4 t o 1 7 y e a r s , and compared w i t h t h a t o f 54 normal age-and sex-matched c o n t r o l s .
458A
A l l p a t i e n t s had had r e g u l a r menses one o r more y e a r s b e f o r e t h e s t a r t o f t h e a m e n o r r h e i c p e r i o d . A t t h e t i m e o f BUD e v a l u a t i o n amenorrhea ranged from 2 t o 12 months, w e i g h t l o s s from 13% t o 41%, mean v a l u e 33.9% i n r e l a t i o n t o i d e a l h e i g h t f w s i g h t r a t i o , and body mass index from 1 3 . 4 1 t o 17.70, mean v a l u e 1 5 . 2 1 .
BMD was l e s s t h a n -1 SD o f normal age-matched c o n t r o l s i n f i v e p a t i e n t s and h i g h e r i n f o u r . No c a r i s l a t i o n was found between BUD v a l u e s and w e i g h t l o s s , o r w i t h body mass i n d e x . However, a s i g n i f i c a n t and s t a t i s t i c a l l y n e g a t i v e c o r r e l a t i o n was found between BMD v a l u e s and t h e p e r i o d o f amenorrhea ( r= -0.80. o< 0.01. n. 9 I .
. . Follow-up ( 6-14 mo. ) of t h r e e p a t i e n t s w i t h BUD v a l u e s l e s s t h a n -lSD, showed no i n c r e a s e i n BMD v a l u e s d e s p i t e a s i g n i f i c a n t w e i g h t g a i n ( body maas index changed from 1 3 . 6 8 t/-0 . 3 t o 17.88 +/-2.27 , p<0.01, n = 3 ) . A 1 1 t h r e e p a t i e n t s remained a m e n o r r h e i c d u r i n g t h i s p e r i o d .
I n c o n c l u s i o n , BUD v a l u e a a r e d e c r e a s e d i n some p a t i e n t s w i t h a n o e e x l a n e r v o s a . BMD v a l u e s c o r r e l a t e d n e g a t i v e l y w i t h t h e d u r a t i o n of amenorrhea. The s i g n i f i c a n t w e i g h t i n c r e a s e i n t h e s e p a t i e n t s was n o t accompanied by a p a r a l l e l BMV i n c r e a s e s i n c e amenorrhea p e r s i s t e d d u r i n g t h i s p e r i o d . Our r e s u l t s S80 u n d e r l i n e t h e i m p o r t a n c e of e s t r o g e n s i n t h e m a i n t e n a n c e Of BMD v a l u e s i n f e m a l e a d o l e s c e n t p a t i e n t s .
